Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001021919 | SCV001183595 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-04-12 | criteria provided, single submitter | clinical testing | The p.T1376A variant (also known as c.4126A>G), located in coding exon 10 of the BRCA1 gene, results from an A to G substitution at nucleotide position 4126. The threonine at codon 1376 is replaced by alanine, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Invitae | RCV001862197 | SCV002126562 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2023-09-15 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BRCA1 protein function. ClinVar contains an entry for this variant (Variation ID: 824612). This variant has not been reported in the literature in individuals affected with BRCA1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 1376 of the BRCA1 protein (p.Thr1376Ala). |
CHEO Genetics Diagnostic Laboratory, |
RCV003492209 | SCV004240264 | uncertain significance | Breast and/or ovarian cancer | 2023-03-01 | criteria provided, single submitter | clinical testing | |
Center for Precision Medicine, |
RCV002250716 | SCV002520861 | uncertain significance | Familial cancer of breast | no assertion criteria provided | curation |